Chemistry Ventures Raises $500M for Second Fund

Chemistry Ventures, a venture‑capital firm founded by alumni of Bessemer Venture Partners, Index Ventures, and Andreessen Horowitz, has announced it is raising $500 million for its second fund. The new capital round follows the firm’s successful launch of its inaugural fund, which focused on early‑stage technology companies across software, hardware, and life sciences.

The $500 million target reflects Chemistry Ventures’ strategy to deepen its investment reach and support a broader portfolio of founders. Lead investors for the round include several of the firm’s founding partners, with commitments also coming from a mix of strategic corporate investors and other venture funds. The capital will be deployed across sectors such as artificial intelligence, fintech, and biotech, with an emphasis on companies that combine strong technical foundations with scalable business models.

Chemistry Ventures plans to close the fund in the coming months, aiming to deploy capital through 2025 and beyond. The firm’s leadership highlighted the growing demand for early‑stage capital in high‑growth technology sectors, positioning the new fund to capture emerging opportunities while maintaining its focus on founder‑centric investing.